Scientists at University of California San Diego School of Medicine have shed new light on the development of liver cancer, the sixth most frequently diagnosed cancer and fourth leading cause of cancer deaths worldwide.
Fresenius Kabi wins FDA approval for Stelara biosimilar Otulfi – Pharmaceutical Technology
Fresenius Kabi now has four FDA-approved biosimilars. Image credit: Shutterstock/ JHVEPhoto. Fresenius Kabi and Formycon have won US Food and Drug Administration (FDA) approval for
October 1, 2024